UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report February 11,
2011
(Date of
earliest event reported)
Commission
File Number 0-16211
|
DENTSPLY
International Inc.
|
|
(Exact
name of registrant as specified in its
charter)
|
|
Delaware
|
39-1434669
|
|
(State
of Incorporation)
|
(IRS
Employer Identification No.)
|
|
221
West Philadelphia Street,
|
|
|
York, Pennsylvania
|
17405-0872
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant's
telephone number, including area code:
|
|
(717)
845-7511
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02 – Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Mr.
Willie A. Deese was appointed to the Board of Directors of the Company on
February 11, 2011. Attached is a copy of the Press Release announcing Mr.
Deese’s appointment. A decision has not yet been made as to the Board
Committee to which Mr. Deese will be assigned. Mr. Deese will participate in the
same compensation plans as the other Directors, which are the Directors Deferred
Compensation Plan and the Company’s Equity Incentive Plan.
Item
9.02 Financial Statements and Exhibits
(d) Exhibits:
99.1 DENTSPLY
International Inc. press release dated February 11, 2011
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
| DENTSPLY INTERNATIONAL INC. | |||
|
|
By:
|
/s/ Brian M. Addison | |
| Brian M. Addison | |||
| Vice President, Secretary and General Counsel | |||
Date:
February 14, 2011
 |
DENTSPLY
International
World
Headquarters
Susquehanna
Commerce Center
221
West Philadelphia St.
York,
PA 17405-0872
(717)
849-4243 Direct
(717)
849-4756 Fax
|
News
For
further information contact:
Michele
E. Mummert
Manager,
Corporate Communications
Phone
717-849-4465
Email:
michele.mummert@dentsply.com For Immediate
Release
DENTSPLY
INTERNATIONAL NAMES WILLIE A. DEESE AS DIRECTOR
York, PA
– February 11, 2011 – DENTSPLY International Inc. (NASDAQ-XRAY) announced today
that Willie A. Deese has been appointed to serve as a member of the Board of
Directors with his initial term expiring at the 2012 Annual Meeting of
Shareholders. Mr. Deese is Executive Vice President of Merck & Co., Inc. and
has been President of the Merck Manufacturing Division since May 2005. In this
role, Mr. Deese oversees 92 manufacturing sites spanning 30 countries, has led
manufacturing for the introduction of multiple new medicines and vaccines, and
implemented lean manufacturing across the company's manufacturing network. Mr.
Deese joined Merck, a $46 billion global biopharmaceutical company, in January
2004 as Senior Vice President of Global Procurement.
Throughout
his career, Mr. Deese has been actively involved in the operational and
financial aspects of several market leading companies, with more than a decade
of senior executive experience. Mr. Deese began his career in 1976 at Digital
Equipment Corp. in Springfield, Mass. and joined SmithKline Beecham
Pharmaceuticals in Philadelphia in 1992, ultimately becoming Vice President and
Director, Purchasing. In 1996, Mr. Deese served as Vice President of Purchasing,
at Kaiser Permanente in Oakland, Calif. In 1997, he returned to SmithKline
Beecham as Senior Vice President and Director of Purchasing. Mr. Deese led the
integration of the Glaxo and SmithKline procurement organizations through their
merger, becoming Senior Vice President, Global Procurement and Logistics for
GlaxoSmithKline in 2001.
|
|
Mr. Deese
earned his B.A. in Business Administration at North Carolina A&T State
University in 1977, and his M.B.A. at Western New England College in
1983.
Bret
Wise, DENTSPLY's Chairman and Chief Executive Officer, states, “Our Company is
pleased to have someone with Mr. Deese’s broad executive experience and talent
join our Board of Directors. Willie is highly regarded in the pharmaceutical
industry and will contribute to DENTSPLY’s successful achievement of strategic
business initiatives.”
DENTSPLY
designs, develops, manufactures and markets a broad range of professional dental
products including dental implants, endodontic instruments and materials,
orthodontic appliances, restorative materials, preventive materials and devices,
and prosthetic materials and devices. The Company distributes its dental
products in over 120 countries under some of the most well-established brand
names in the industry.
DENTSPLY
is committed to the development of innovative, high quality, cost-effective new
products for the dental market.
###